$10.17
0.00 (0%)
Enzon Pharmaceuticals, Inc. (ENZN)
CAPS Rating:
A biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and adjacent diseases.


RSS Headlines
Fool UK